| For: | Al Bitar S, El-Sabban M, Doughan S, Abou-Kheir W. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond. World J Gastroenterol 2023; 29(9): 1395-1426 [PMID: 36998426 DOI: 10.3748/wjg.v29.i9.1395] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v29/i9/1395.htm |
| Number | Citing Articles |
| 1 |
Yi Zhou, Jiahao Shi, Mengjie Zhang, Hua Yang, Jian Fei. The Interventional Effects and Mechanisms of Lonidamine in Combination with Apigenin on Colorectal Cancer. Current Issues in Molecular Biology 2025; 47(10) doi: 10.3390/cimb47100825
|
| 2 |
Anggraeni E. Kusumaningrum, Sarce Makaba, Eyhab Ali, Mandeep Singh, Mohammed N. Fenjan, Irodakhon Rasulova, Neeti Misra, Sada G. Al‐ Musawi, Ali Alsalamy. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance. Cell Biochemistry and Function 2024; 42(1) doi: 10.1002/cbf.3906
|
| 3 |
Sikhumbuzo Z. Mbatha, Rupert C. Ecker, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00005-6
|
| 4 |
Da-Mao Liu, Xian-Yu Yang, Hui-Hua Zheng, Pan-Min Chen, Shu-Kun Zeng, Yu-Feng Wei. Impact of primary colorectal cancer site on surgical outcomes for liver metastases: A retrospective study. World Journal of Gastrointestinal Surgery 2025; 17(11): 111138 doi: 10.4240/wjgs.v17.i11.111138
|
| 5 |
Wen-Yu Luan, Hao Lin, Yan-Dong Miao. Recommendations for articles and reviews in colorectal cancer-related research at the year-end of 2023. World Journal of Gastroenterology 2024; 30(30): 3548-3553 doi: 10.3748/wjg.v30.i30.3548
|
| 6 |
Mingtang Zeng, Yao Wang, Xuelin Tao, Tianfei Fan, Xi Yin, Chao Shen, Xueyan Wang. Novel Perspectives in the Management of Colorectal Cancer: Mechanistic Investigations Into the Reversal of Drug Resistance via Active Constituents Derived From Herbal Medicine. Phytotherapy Research 2024; 38(12) doi: 10.1002/ptr.8363
|
| 7 |
Sathan Raj Natarajan, Rajapandiyan Krishnamoorthy, Mohammad A. Alshuniaber, Khalid Mashay Al-Anazi, Mohammad Abul Farah, Ponnulakshmi Rajagopal, Chella Perumal Palanisamy, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman. Identification of FOXM1 as a novel protein biomarker and therapeutic target for colorectal cancer progression: Evidence from immune infiltration and bioinformatic analyses. International Journal of Biological Macromolecules 2024; 282 doi: 10.1016/j.ijbiomac.2024.137201
|
| 8 |
Omar A. Oudit, Temitayo Adebowale, Abdulrahman Atasi, Kibwey Peterkin, Jamal Perry, Chidiebele E. Omaliko, Jamil Shah. The Impact of Aspirin Use on In-Hospital Outcomes and Metastatic Disease in Colorectal Cancer: An Evaluation of the National Inpatient Sample. Journal of Clinical Medicine 2026; 15(10) doi: 10.3390/jcm15103894
|
| 9 |
Amir Torshizi Esfahani, Somayeh Mohammadpour, Pooya Jalali, Alireza Yaghoobi, Raana Karimpour, Soha Torkamani, Ali Pardakhtchi, Zahra Salehi, Ehsan Nazemalhosseini-Mojarad. Differential expression of angiogenesis-related genes ‘VEGF’ and ‘angiopoietin-1’ in metastatic and EMAST-positive colorectal cancer patients. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61000-x
|
| 10 |
Harikumar Pallathadka, Chou-Yi Hsu, Raed Obaid Saleh, S. Renuka Jyothi, Ashwani Kumar, Alexey Yumashev, Aashna Sinha, Ahmed Hussein Zwamel, Mohammed Abed Jawad, Salim B. Alsaadi. Specific small interfering RNAs (siRNAs) for targeting the metastasis, immune responses, and drug resistance of colorectal cancer cells (CRC). International Immunopharmacology 2024; 140 doi: 10.1016/j.intimp.2024.112730
|
| 11 |
Elham Farrokhnazar, Sahar Moghbelinejad, Reza Najafipour, Ladan Teimoori-Toolabi. MiR-3664-3p through suppressing ABCG2, CYP3A4, MCL1, and MLH1 increases the sensitivity of colorectal cancer cells to irinotecan. Heliyon 2025; 11(3) doi: 10.1016/j.heliyon.2025.e41933
|
| 12 |
Se Lim Kim, Min Woo Shin, Byung Chul Jin, Seung Young Seo, Sang Wook Kim. The Combination of PF-543 and TRAIL Effectively Induces Apoptotic Cell Death and Inhibits Stem Cell-Like Properties Through the SPHK1/S1PR1/STAT3 Pathway in TRAIL-Resistant Colorectal Cancer Cells. Digestive Diseases and Sciences 2025; 70(9) doi: 10.1007/s10620-025-09091-y
|
| 13 |
Mohd Farhan. Insights on the Role of Polyphenols in Combating Cancer Drug Resistance. Biomedicines 2023; 11(6) doi: 10.3390/biomedicines11061709
|
| 14 |
Lizhe Huang, Cun Liao, Zuming Xiong, Zhongyang Chen, Sen Zhang. Hsa-miR-526b-5p Regulates the Sensitivity of Colorectal Cancer to 5-Fluorouracil by Targeting TP53 in Organoid Models. Biochemical Genetics 2026; 64(1) doi: 10.1007/s10528-025-11045-y
|
| 15 |
Xinyang Huang, Shenghui Huang, Chiara Reina, Berina Šabanović, Miriam Roberto, Alexandra Aicher, Jiajia Tang, Christopher Heeschen. Single-cell multi-omics and machine learning for dissecting stemness in cancer. Briefings in Bioinformatics 2025; 26(5) doi: 10.1093/bib/bbaf566
|
| 16 |
Shuoxi Guo, Meiqi Chen, Shuangyang Li, Zijun Geng, Ye Jin, Da Liu. Natural Products Treat Colorectal Cancer by Regulating miRNA. Pharmaceuticals 2023; 16(8) doi: 10.3390/ph16081122
|
| 17 |
Elise Pretzsch, Christiane A. Peschel, Matjaz Rokavec, Lucien Torlot, Pan Li, Heiko Hermeking, Jens Werner, Frederick Klauschen, Jens Neumann, Andreas Jung, Jörg Kumbrink. Five-Gene Expression Signature Associated With Acquired FOLFIRI Resistance and Survival in Metastatic Colorectal Cancer. Laboratory Investigation 2025; 105(5) doi: 10.1016/j.labinv.2025.104107
|
| 18 |
Anjing Zhao, Xingchao Zhu, Hongya Wu, Jiayu Wang, Mengting Zhang, Jingrong Xiang, Suhua Xia, Tongguo Shi, Qinhua Xi. B7-H3 promotes the migration and invasion of colorectal cancer cells via regulating the actin cytoskeleton and RhoA/ROCK1/LIMK1 signaling pathway. Tissue and Cell 2024; 90 doi: 10.1016/j.tice.2024.102518
|
| 19 |
Julia Pospieszna, Hanna Dams-Kozlowska, Wachirawit Udomsak, Marek Murias, Malgorzata Kucinska. Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets. International Journal of Molecular Sciences 2023; 24(13) doi: 10.3390/ijms241310910
|
| 20 |
Yue Chen, Jiaqi Zhang, Yi Ding, Fang Zhu, Yinnan Chen. Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances. Molecular Biomedicine 2026; 7(1) doi: 10.1186/s43556-026-00433-4
|
| 21 |
Jia Fan, Jin Gu, Baoqing Jia, Jin Li, Xinyu Qin, Xishan Wang, Jianmin Xu, Ruihua Xu, Yingjiang Ye, Suzhan Zhang, Zhongtao Zhang. Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastasis (2025 Edition). Clinical Cancer Bulletin 2026; 5(1) doi: 10.1007/s44272-026-00062-6
|
| 22 |
Elahe Shams, Elahe Daskar Abkenar, Negin Sina, Sara Ebrahimi, Mona Malekzadeh Moghani, Amir Sadeghi, Stefania Nobili, Ehsan Nazemalhosseini Mojarad, Nayeralsadat Fatemi. Non-Coding RNAs and cernas: emerging modulators of drug response in colorectal cancer. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-025-11349-7
|
| 23 |
Wei Wang, Jing Wang, Xiu-Xiu Ren, Hai-Long Yue, Zheng Li. Effects of invigorating-spleen and anticancer prescription on extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway in colon cancer mice model. World Journal of Gastrointestinal Oncology 2024; 16(11): 4468-4476 doi: 10.4251/wjgo.v16.i11.4468
|
| 24 |
Ya-Rui Liu, Ying Zeng, Chao Mei, Yun-Hua Xu, Hai-Bo Zhang, Rui Liang, Guo Wang. Identification of GPD1L as a potential prognosis biomarker and associated with colorectal cancer progression. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-025-04337-7
|
| 25 |
Huihai Yang, Grace Gar-Lee Yue, Ping-Chung Leung, Chun-Kwok Wong, Ying-Jun Zhang, Clara Bik-San Lau. Human epidermal growth factor receptor 2 as a target of 1,2,3,4,6-penta-O-galloyl-β-d-glucose in colon cancer. Journal of Pharmacy and Pharmacology 2026; 78(2) doi: 10.1093/jpp/rgaf098
|
| 26 |
Yuanfang Cheng. Small protein DDX11-AS1-ORF encoded by lncRNA DDX11-AS1 promotes colorectal cancer progression through VEGFA-activated p38-MAPK pathway. American Journal of Cancer Research 2025; 15(4) doi: 10.62347/VRJE7714
|
| 27 |
Wanmei Lin, Lijun Xu, Yaoying Li, Junze Li, Liang Zhao. Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing. Oncogene 2024; 43(48) doi: 10.1038/s41388-024-03189-9
|
| 28 |
Francisco Pérez-Domínguez, Claudia Quezada-Monrás, Leonardo Cárcamo, Juan P. Muñoz, Diego Carrillo-Beltrán. Oncolytic Viruses as a Novel Therapeutic Approach for Colorectal Cancer: Mechanisms, Current Advances, and Future Directions. Cancers 2025; 17(11) doi: 10.3390/cancers17111854
|
| 29 |
Caterina Mancini, Giulia Lori, Gianluca Mattei, Marta Iozzo, Dayana Desideri, Fabio Cianchi, Laura Fortuna, Federico Passagnoli, Daniela Massi, Filippo Ugolini, Luca Messerini, Salvatore Piscuoglio, Antonio Pezone, Francesca Magherini, Alessio Biagioni, Tiziano Lottini, Demetra Zambardino, Giuseppina Ivana Truglio, Elena Petricci, Alberto Magi, Annarosa Arcangeli, Luisa Maresca, Barbara Stecca, Erica Pranzini, Maria Letizia Taddei. PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signaling. Journal of Experimental & Clinical Cancer Research 2025; 44(1) doi: 10.1186/s13046-025-03447-y
|
| 30 |
Dennis C. George, Fred E. Bertrand, George Sigounas. Notch-3 affects chemoresistance in colorectal cancer via DNA base excision repair enzymes. Advances in Biological Regulation 2024; 91 doi: 10.1016/j.jbior.2024.101013
|
| 31 |
Xu Zhang, Liping Wang, Tong Fu, Xuchu Duan, Hao Wang, Yuqing Chen, Xiaoyu Liu. Decoding colorectal cancer lung metastasis: a global research odyssey. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1587422
|
| 32 |
Xiang-Yuan Tao, Qian-Qian Li, Yong Zeng. Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02063-2
|
| 33 |
Qiannan Liu, Shanshan Tang, Le Yang, Farong Ou, Kan Li, Huanzi Lu, Zengyu Chen, Guiqing Liao, Yujie Liang. Clinical outcomes and prognostic factors in multiple primary malignancies involving oral cancer. BMC Oral Health 2025; 25(1) doi: 10.1186/s12903-025-06141-9
|
| 34 |
Hossein Maghsoudi, Motahareh Rasoulzadeh, Maryam Abbastabar, Ahmad Fazilat, Farhad Sheikhnia, Bita Azizzadeh, Mohamad Valilo, Maryam Majidinia. The lncrnas: innovative multifunctional players of drug resistance in colorectal cancer. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03951-3
|
| 35 |
Xiangyu Meng, Xiao Bai, Angting Ke, Kaiqiang Li, Yun Lei, Siqi Ding, Dongqiu Dai. Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications. Biomolecules 2024; 14(6) doi: 10.3390/biom14060608
|
| 36 |
Ki-Hyun Kim, Young-Lan Park, Sun-Young Park, Young-Eun Joo. Expression of an oxysterol-metabolizing enzyme in colorectal cancer and its relation to tumor cell behavior and prognosis. Pathology - Research and Practice 2023; 251 doi: 10.1016/j.prp.2023.154875
|
| 37 |
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia. Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09431-7
|
| 38 |
Lloyd Mabonga, Rebecca Leony Fourie, Abidemi Paul Kappo, Sylvester Lyantagaye, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00001-9
|
| 39 |
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, Maryam Zulfiqar, Shehzeen Noor, Laiba Nazakat, Muhammad Abdullah Javed. Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer. Journal of Oncology Pharmacy Practice 2025; 31(7) doi: 10.1177/10781552251324896
|
| 40 |
Fangyuan Zhou, Luorui Shang, Jinxiao Li, Mengqi Zhang, Shuhan Wang, Yuju Cai, Qifeng Lin, Haiyang Gao, Shenglan Yang. Erianin reverses 5-FU resistance by targeting CALM1/CAMKK2 and activating autophagy in colorectal cancer. Chemico-Biological Interactions 2025; 421 doi: 10.1016/j.cbi.2025.111750
|
| 41 |
Yoonsuk Lee, Yun Young Lee, Jinyoung Park, Anna Maksakova, Donghyuk Seo, Jisun Kim, Ji Eun Yeom, Yewon Kim, Cheol-Hwi Kim, Rhim Ryoo, Se-Na Kim, Juwon Park, Wooram Park, Tae-Hyung Kim, Young Bin Choy, Chun Gwon Park, Ki Hyun Kim, Wonhwa Lee. Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer. Biomedicine & Pharmacotherapy 2025; 182 doi: 10.1016/j.biopha.2024.117795
|
| 42 |
Semra Demirli Atici, Aras Emre Canda, Mustafa Cem Terzi. Integrating inflammation, nutrition, and artificial intelligence: A new era in colorectal cancer prognostic scoring. World Journal of Gastroenterology 2025; 31(30): 108431 doi: 10.3748/wjg.v31.i30.108431
|
| 43 |
Martina Lepore Signorile, Elisabetta Di Nicola, Giovanna Forte, Paola Sanese, Candida Fasano, Vittoria Disciglio, Katia De Marco, Marialaura Latrofa, Loris De Cecco, Marica Ficorilli, Marta Lucchetta, Erica Torchia, Chiara Dossena, Giusy Bianco, Vito Spilotro, Claudia Ferroni, Nicoletta Labarile, Raffaele Armentano, Francesco Albano, Anna Mestice, Gianluigi Gigante, Valerio Lantone, Giuliano Lantone, Leonardo Vincenti, Alberto Del Rio, Greta Varchi, Valentina Grossi, Cristiano Simone. Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02290-z
|
| 44 |
Hongyuan Shen, Jia Li, Guoqing Wang, Xiangyu Su, Zhigang Zhang, Jinjun Shi. Proteomic landscape of colorectal cancer liver metastasis: molecular signatures and novel therapeutic targets. PeerJ 2026; 14 doi: 10.7717/peerj.20856
|
| 45 |
Hailang Jiang, Bingtian Xu. The critical role of epithelial-mesenchymal transition (EMT) in colorectal cancer progression and therapeutic outcomes. Critical Reviews in Oncology/Hematology 2026; 220 doi: 10.1016/j.critrevonc.2026.105189
|
| 46 |
Sara Cherri, Ester Oneda, Laura Zanotti, Alberto Zaniboni. Optimizing the first-line treatment for metastatic colorectal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1246716
|
| 47 |
Hu Chenghao, Liu Xuefeng, Pang Junli, Wang Ke, Li Haixia, Hu Guangyue, Luo Qingqin, Wu Feng. Mitochondrial-targeting strategies with homoharringtonine: A novel approach for chemoresistant rectal cancer. Biochemical and Biophysical Research Communications 2025; 743 doi: 10.1016/j.bbrc.2024.151141
|
| 48 |
Beatriz Leme Boaro, Enzo Pereira de Lima, Durvanei Augusto Maria, Rose Eli Grassi Rici, Adriano Cressoni Araújo, Elen Landgraf Guiguer, Eliana de Souza Bastos Mazuqueli Pereira, Caroline Barbalho Lamas, Claudia Rucco Penteado Detregiachi, Adriana Maria Ragassi Fiorini, Antonely de Cássio Alves de Carvalho, Lucas Fornari Laurindo, Sandra Maria Barbalho. Cinobufagin: Unveiling the hidden bufadienolide’s promise in combating alimentary canal cancer development and progression – a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(7) doi: 10.1007/s00210-025-03902-9
|
| 49 |
Ming Jiang, Wenjuan Li, Jinzhe Liang, Min Pang, Shanhe Li, Gang Xu, Minghui Zhu, Hong Liang, Zhenlei Zhang, Feng Yang. Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response. Journal of Medicinal Chemistry 2024; 67(18) doi: 10.1021/acs.jmedchem.4c01175
|
| 50 |
Jun Wang, Lijuan Zhu, Yuanyuan Li, Mingming Ding, Xiyu Wang, Bo Xiong, Hongyu Chen, Lisheng Chang, Wenli Chen, Bo Han, Jun Lu, Qin Shi. Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulation. Frontiers in Genetics 2025; 16 doi: 10.3389/fgene.2025.1560172
|
| 51 |
Jiasheng Li, Shanshan Ma, Qiuhua Lin, Qin Wang, Wuning Zhong, Chunyin Wei, Junjie Liu, Jie Chen, Duo Wang, Weizhong Tang, Tao Luo. Orchestrated copper-loaded nanoreactor for simultaneous induction of cuproptosis and immunotherapeutic intervention in colorectal cancer. Materials Today Bio 2024; 29 doi: 10.1016/j.mtbio.2024.101326
|
| 52 |
Shurong Huang, Zongda Cai, Yangqiang Wang, Wei Zheng, Shiyang Zhan, Mingjin Huang, Jinping Chen. USP32 stabilizes SEMA4C to promote malignant behavior of colon cancer cells. Pathology - Research and Practice 2025; 274 doi: 10.1016/j.prp.2025.156162
|
| 53 |
Sheema Hashem, Ajaz A. Bhat, Sabah Nisar, Shahab Uddin, Maysaloun Merhi, Jericha M. Mateo, Kirti S. Prabhu, Lama Soubra, Carlos Andre dos Santos-Silva, Ana Maria Benko-Iseppon, Lívia Maria Batista Vilela, Marx Oliveira de Lima, Juliana Georgia da Silva, Mohammad Haris, Muhammad Suleman, Sergio Crovella, Haissam Abou-Saleh. Engineered Anti-Microbial Peptides Inhibit Cell Viability, Promote Apoptosis, and Induce Cell Cycle Arrest in SW620 Human Colon Adenocarcinoma Cells. Current Protein & Peptide Science 2025; 26(7) doi: 10.2174/0113892037363898250110053529
|
| 54 |
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia. WEE1 Inhibition by AZD1775 Augments Colorectal Cancer Cells
Susceptibility to VE-822-induced DNA Damage and Apoptosis. Drug Research 2025; 75(02) doi: 10.1055/a-2499-3067
|
| 55 |
Cristina Mesas, Ana Guzmán-Carrasco, Kevin Doello, Jesús M. Porres, Rosario Martínez, Mercedes Peña, Consolación Melguizo, Jose Prados. Antitumor properties of an ethanolic extract from seeds of Solanum melongena L.: in vitro and in vivo study in colon cancer. Food Bioscience 2025; 71 doi: 10.1016/j.fbio.2025.106970
|
| 56 |
Surbhi Singh, Vaibhav Nigam, Shivani Kasana, Balak Das Kurmi, Ghanshyam Das Gupta, Preeti Patel. Targeting c-Met in Cancer Therapy: Unravelling Structure-activity Relationships and Docking Insights for Enhanced Anticancer Drug Design. Current Topics in Medicinal Chemistry 2025; 25(4) doi: 10.2174/0115680266331025241015084546
|
| 57 |
Yan-Xu Hou, Wei Ren, Qing-Qiang He, Li-Yan Huang, Tian-Hua Gao, Hua Li. Tetramethylpyrazine induces reactive oxygen species-based mitochondria-mediated apoptosis in colon cancer cells. World Journal of Gastrointestinal Oncology 2025; 17(4): 104922 doi: 10.4251/wjgo.v17.i4.104922
|
| 58 |
Juan Zhang, Zhihan Li, Jiaxu Han, Zhongtao Tian, Qingyu Meng, Wenbo Niu. KLF7 enhances the invasion and migration of colorectal cancer cells via the miR-139-5p/TPD52 axis. Cancer Biology & Therapy 2024; 25(1) doi: 10.1080/15384047.2024.2385172
|